The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I

Timothy M.E. Davis; Wendy A. Davis

doi:10.1111/imj.15846

The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I

Timothy M.E. Davis, Wendy A. Davis

Internal Medicine

Research output: Contribution to journal › Article › peer-review

1 Citation (Web of Science)

Abstract

Pancreatic cancer incidence was double (incidence rate ratio 2.06) in community-based adults with (n = 1291) versus without (n = 5158) type 2 diabetes followed for up to 25 years in the Fremantle Diabetes Study Phase 1. Sustained higher fasting plasma glucose reflecting insulin resistance and fewer comorbidities were statistically significant risk factors in the cohort with diabetes. Past pancreatitis was an aetiologically significant determinant in the cohort as a whole.

Original language	English
Pages (from-to)	1258-1262
Number of pages	5
Journal	Internal Medicine Journal
Volume	52
Issue number	7
DOIs	https://doi.org/10.1111/imj.15846
Publication status	Published - Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/imj.15846

Cite this

@article{c505d4f22cd04247b29f4561af2c4510,

title = "The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I",

abstract = "Pancreatic cancer incidence was double (incidence rate ratio 2.06) in community-based adults with (n = 1291) versus without (n = 5158) type 2 diabetes followed for up to 25 years in the Fremantle Diabetes Study Phase 1. Sustained higher fasting plasma glucose reflecting insulin resistance and fewer comorbidities were statistically significant risk factors in the cohort with diabetes. Past pancreatitis was an aetiologically significant determinant in the cohort as a whole.",

keywords = "incidence, pancreatic cancer, risk factors, type 2 diabetes",

author = "Davis, {Timothy M.E.} and Davis, {Wendy A.}",

year = "2022",

month = jul,

doi = "10.1111/imj.15846",

language = "English",

volume = "52",

pages = "1258--1262",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "John Wiley & Sons",

number = "7",

}

TY - JOUR

T1 - The relationship between pancreatic cancer and type 2 diabetes

T2 - the Fremantle Diabetes Study Phase I

AU - Davis, Timothy M.E.

AU - Davis, Wendy A.

PY - 2022/7

Y1 - 2022/7

N2 - Pancreatic cancer incidence was double (incidence rate ratio 2.06) in community-based adults with (n = 1291) versus without (n = 5158) type 2 diabetes followed for up to 25 years in the Fremantle Diabetes Study Phase 1. Sustained higher fasting plasma glucose reflecting insulin resistance and fewer comorbidities were statistically significant risk factors in the cohort with diabetes. Past pancreatitis was an aetiologically significant determinant in the cohort as a whole.

AB - Pancreatic cancer incidence was double (incidence rate ratio 2.06) in community-based adults with (n = 1291) versus without (n = 5158) type 2 diabetes followed for up to 25 years in the Fremantle Diabetes Study Phase 1. Sustained higher fasting plasma glucose reflecting insulin resistance and fewer comorbidities were statistically significant risk factors in the cohort with diabetes. Past pancreatitis was an aetiologically significant determinant in the cohort as a whole.

KW - incidence

KW - pancreatic cancer

KW - risk factors

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85134760176&partnerID=8YFLogxK

U2 - 10.1111/imj.15846

DO - 10.1111/imj.15846

M3 - Article

C2 - 35879240

AN - SCOPUS:85134760176

SN - 1444-0903

VL - 52

SP - 1258

EP - 1262

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 7

ER -

The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this